Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rochelle Castillo

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Rheumatology (Oxford, England)|May 31, 2022
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritisRebecca B Blank, Rebecca H Haberman, Kun Qian, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Rheumatology (Oxford, England)|May 31, 2022
Low incidence and transient elevation of autoantibodies post mRNA COVID-19 vaccination in inflammatory arthritisRebecca B Blank, Rebecca H Haberman, Kun Qian, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
Methotrexate Hampers Immunogenicity to BNT162b2 mRNA COVID-19 Vaccine in Immune-Mediated Inflammatory DiseaseRebecca H Haberman, Ramin Sedaghat Herati, David Simon, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Pageof 3